Progress in biophysics and molecular biology · 2026
Biophysical and molecular mechanisms of lysosomal mechanoresilience: Membrane tension, TMEM63A, and cellular injury.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hamad Rabab S, El-Kott Attalla F, Negm Sally, AlShehri Mohammed A, Eltantawy Waleed, Elmorsy Elsayed A, Abdel-Aal Ebtehal M, Hamza Eman, Saber Sameh
Аннотация
Lysosomal membrane failure contributes to cellular injury by disrupting degradation, metabolism, immune signaling, and compartmental integrity, yet the physical principles that determine whether a mechanically loaded lysosome adapts or ruptures remain incompletely resolved. This review integrates biophysical and molecular evidence to examine lysosomal membrane tension as an organelle-state variable and TMEM63A as an emerging determinant of lysosomal mechanoresilience. We distinguish membrane tension from hydrostatic and osmotic pressure, organelle volume, membrane permeabilization, and rupture, and evaluate how surface-area-to-volume constraints, luminal solute accumulation, ion and water flux, membrane potential, lipid composition, and force-from-lipid gating shape mechanical failure thresholds. The strongest evidence comes from Drosophila TMEM63 and mouse TMEM63A lysosomal mechanosensitivity and macrophage models in which TMEM63A-dependent cation efflux lowers acute membrane tension and rupture susceptibility. Together, these findings support a pressure-relief model coupling mechanically activated conductance to lysosomal membrane stability. Evidence from lysosome-related organelles, lipid scrambling, myelination, infection, and pressure-sensitive mTORC1-TFEB/TFE3 signaling broadens the mechanistic scope without establishing a universal TMEM63A-dependent pathway. Accordingly, TMEM63A is best viewed as a system- and condition-dependent regulator of acute lysosomal mechanical vulnerability, not a general lysosomal controller or validated therapeutic target. Importantly, TMEM63A-linked disease phenotypes in humans and Tmem63a-deficient mice have not been causally linked to impaired lysosomal mechanoresilience, and the macrophage pressure-relief mechanism remains unvalidated in vivo. Resolving these uncertainties will require simultaneous, time-resolved measurements of tension, geometry, ion composition, membrane potential, permeability, and repair, combined with compartment-specific localization and rescue using wild-type, pore-defective, localization-defective, and disease-associated variants.